Rebecca Tisdale MD, MPA (@beccatis) 's Twitter Profile
Rebecca Tisdale MD, MPA

@beccatis

Virtual care + ♥️ disease + global health + health services @vahsrd. Alum @ci2ifellowships / @stanfordchiefs / @stanmedres / @columbiaps / @stanford

ID: 78052970

calendar_today28-09-2009 16:18:38

68 Tweet

211 Takipçi

294 Takip Edilen

Rebecca Tisdale MD, MPA (@beccatis) 's Twitter Profile Photo

And what a joyous reunion it was! Forever grateful to Ronald Witteles Angela Rogers et al for letting me do this job, w these beyond-wonderful co-chiefs @Surbhi_Singhal2 Amy Rogers Filsoof & our fantastic residents. Special thx Karina Delgado-Carrasco for getting dinner to happen at last!

Rebecca Tisdale MD, MPA (@beccatis) 's Twitter Profile Photo

When deciding on length of vancomycin treatment for a patient with IBD and C diff and your StanfordMedRes resident Philip Sossenheimer casually reveals he has authored seminal papers on that exact Q 🤯 #medtwitter #ebm journals.lww.com/ajg/Abstract/2…

Charlie M. Wray, DO, MS (@wraycharles) 's Twitter Profile Photo

Rebecca Tisdale MD, MPA & I discussing this interesting paper in JAMA Network Open on the concordance of virtual to in-person diagnosis. jamanetwork.com/journals/jaman… Authors find concordance rate of 87%. Not gonna lie, this seems high? Or, am I truly underestimating the power of virtual care?

Nikhil Narang, MD (@nikhil15) 's Twitter Profile Photo

New work in #JACCHF Celeste Witting Franklin, MD Alex Sandhu on a VA cohort analysis of pts w/ new HFrEF, studying GDMT implementation + optimization ✅ No significant disparity by race ✅ ⬇️ rate of dose titration in rural pts Opportunity to leverage telemed? 📎 bit.ly/3YtVWK1

New work in #JACCHF <a href="/CelesteWitting/">Celeste Witting Franklin, MD</a> <a href="/ATSandhu/">Alex Sandhu</a> on a VA cohort analysis of pts w/ new HFrEF, studying GDMT implementation + optimization 

✅ No significant disparity by race 
✅ ⬇️ rate of dose titration in rural pts 

Opportunity to leverage telemed? 

📎 bit.ly/3YtVWK1
StanfordHealthPolicy (@stanfordhp) 's Twitter Profile Photo

Stanford Health Policy researchers lead new study that finds screening all U.S. adults 35 and older for Chronic Kidney Disease would increase life expectancy in cost-effective way. 🫘📷 =📷stanford.io/3pXf6Mk

Stanford Health Policy researchers lead new study that finds screening all U.S. adults 35 and older for Chronic Kidney Disease would increase life expectancy in cost-effective way. 🫘📷 =📷stanford.io/3pXf6Mk
Stanford Department of Medicine (@stanforddeptmed) 's Twitter Profile Photo

#StanDOM researchers (including Rebecca Tisdale MD, MPA, Glenn Chertow & Doug Owens) determine that screening everyone aged 35 & over for #ChronicKidneyDisease could be a cost-effective way to increase life expectancy. stan.md/3MP6i2S

Circ: CQO (@circoutcomes) 's Twitter Profile Photo

Sim Pub with #AHA24 in Circ: CQO: Is cost to blame for disparities in access to semaglutide? Not always 📝 shows inequities in Semaglutide Prescriptions persist even in the VA, w/ its universal access to free or low-cost health care 🧵 (1/2)